Key result
Persistent dyspnoea after pulmonary embolism was not independently associated with overall mortality, though it predicted higher mortality in men.
Why the study?
The long-term prognostic significance of persistent dyspnoea after PE remains uncertain, and clinicians struggle to determine whether it reflects post-PE cardiopulmonary sequelae or underlying comorbidity.
Is self-reported persistent dyspnoea following pulmonary embolism independently associated with long-term all-cause mortality?
Cohort (n=4,007)
Yes
Is self-reported persistent dyspnoea following pulmonary embolism independently associated with long-term all-cause mortality?
Answers are grounded in this paper and cite their sources.
Persistent dyspnoea after pulmonary embolism is not an independent predictor of overall long-term all-cause mortality after adjusting for comorbidities, except among men (particularly those aged 50–64 years) where it predicts significantly reduced survival.
Background Persistent dyspnoea is common after pulmonary embolism (PE), yet its long-term prognostic significance remains uncertain. Clinicians often struggle to determine whether dyspnoea reflects post-PE cardiopulmonary sequelae or underlying comorbidity. Purpose We examined whether self-reported dyspnoea following PE is associated with long-term all-cause mortality. Methods We analysed two population-based cohorts: all Swedish patients surviving a PE in 2005 (n=2,104) and participants in a population health survey (n=1,903). Dyspnoea was assessed using identically worded questionnaire items. Comorbidities from national inpatient and outpatient registers were incorporated as time-dependent covariates. Cox proportional hazards models were used to estimate hazard ratios for all-cause mortality, adjusting for age, sex, smoking, and comorbidity burden. Results Dyspnoea was assessed a median of 3.4 years (IQR 3.0–3.7) after the index PE. During a median follow-up of 10.4 years (IQR 5.9–11.3), 906 patients in the PE cohort and 262 reference participants died. Dyspnoea was associated with higher crude mortality in both cohorts (log-rank p<0.001). After adjustment, dyspnoea was not independently associated with mortality in the PE cohort (hazard ratio 1.10, 95% confidence interval 0.94–1.28) or in the reference cohort (hazard ratio 0.86, 95% confidence interval 0.64–1.16). In the PE cohort, a significant interaction with sex was observed: dyspnoea predicted higher mortality in men (hazard ratio 1.35, 95% confidence interval 1.10–1.66) but not in women (hazard ratio 0.85, 95% confidence interval 0.68–1.06; p for interaction=0.009). The association was strongest among individuals aged 50–64 years. No comparable sex- or age-specific patterns were observed in the reference cohort. Conclusions Persistent dyspnoea after PE is associated with reduced survival in crude analyses but is not an independent predictor of mortality overall. Its prognostic relevance appears to vary by sex and age, suggesting that dyspnoea in middle-aged men may indicate clinically relevant post-PE cardiopulmonary impairment.
No takes yet. Share an insight, caveat, or question.
Nilsson et al. (2026) conducted a cohort in Pulmonary embolism (PE) (n=4,007). Self-reported persistent dyspnoea vs. No self-reported dyspnoea was evaluated on Long-term all-cause mortality (HR 1.10, 95% CI 0.94-1.28). Persistent dyspnoea after pulmonary embolism was not independently associated with overall mortality, though it predicted higher mortality in men.
Synapse has enriched 10 related papers. Consider them for comparative context: